Transgenomic Announces $2.375 Million Private Placement Financing
PharmiWeb.com (press release) For each share of common stock purchased investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … |